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Metallothionein (MT) is a low-molecular weight metal-
binding protein. Although the physiologic function of
MT is not fully known, it is present in various species
and various organs including the skin. MT is strongly
stained in hyperplastic epidermal tissues in normal skin
and in hyperplastic skin lesions, and increased expression
of mRNA of the MT gene has been demonstrated in skin
stimulated by proliferative agents, suggesting that MT is
involved in the proliferation of epidermal keratinocytes.
To improve our understanding of the role of MT in
epidermal hyperplasia, mice with null mutations in their
MT-1 and MT-2 genes were used in this study. We
compared the epidermal hyperplasia in MT-null mice
and in normal C57BL/6 J mice after treatments with
cholera toxin, 12–0-tetradecanoylphorbol-13-acetate,
and ultraviolet B irradiation, which stimulate epidermal
Chemical and physical components, such as growth factorsand ultraviolet radiation, elicit epidermal hyperplasia ofthe skin, which involves the biologic network of cellularmetabolisms including metal metabolism.Metallothionein (MT) protein is characterized by its
high cysteine content (µ30%) and has the capacity to selectively bind
heavy metals. There are two types of MT protein (designated MT-1
and MT-2), which differ in their chromatographic behavior. MT is
widely distributed in a broad range of eukaryotic species and in different
tissues and cell types. MT seems to contribute to intracellular metal
homeostasis. In addition to heavy metals (Darum and Palmiter, 1981;
Koizumi et al, 1985), 12-O-tetradecanoylphorbol-13-acetate (TPA)
(Friedman and Stark, 1985), interleukin-1, epidermal growth factor
(Imbra and Karin, 1987), interferon-α (Friedman and Stark, 1985),
glucocorticosteroid (Karin et al, 1980), 1α,25-dihydoxylvitamin D3
(Karasawa et al, 1987), and cholera toxin (Karasawa et al, 1991)
upregulate MT gene expression, suggesting the involvement of MT
in cellular stress reactions.
MT is constitutively expressed in normal and pathologic mouse skin
(Hashiba et al, 1989; Bohm et al, 1990; Karasawa et al, 1991) and
human skin (van den Oord and De Ley, 1994; Rossen et al, 1997). In
normal skin, immunohistochemical staining for MT is weak or absent
in the basal cells of the epidermis. MT staining is also weak in hair
Manuscript received July 9, 1997; revised October 7, 1997; accepted for
publication November 13, 1997.
Reprint requests to: Dr. Katsumi Hanada, Department of Dermatology,
Hirosaki University School of Medicine, Hirosaki 036, Japan.
Abbreviations: MT, metallothionein; PIXE, proton-induced x-ray emission.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
259
proliferation. Immunostaining of MT was not detected
in the skin of MT-null mice, and these mice developed
significantly less epidermal hyperplasia than the normal
mice after exposure to each stimulator. We determined
the metal contents of skin samples by the proton-induced
x-ray emission method. The zinc content of the skin of
the MT-null mice was lower than that of the control
mice before stimulation. After stimulation of epidermal
hyperplasia, MT-null and normal mice showed signific-
antly reduced levels of zinc. These findings indicate that
cellular MT is involved in the proliferative process of the
epidermis induced by cholera toxin, 12–0-tetradecanoyl-
phorbol-13-acetate, and ultraviolet B light through its
regulatory action on the metal metabolism required for
cell growth. Key words: cholera toxin/epidermal hyperplasia/
mutant mouse/PIXE. J Invest Dermatol 110:259–262, 1998
matrix cells of the bulb and the outer root sheath of hair follicles in
the dermis. In hyperplastic skin, induced by TPA or cholera toxin,
MT staining is strong in the basal layer and in the spinous layer of the
epidermis. Immunoreactivity for MT is also noted in the peripheral cells
of sebaceous glands, which are derived from epidermal keratinocytes
(Kuroki, 1981). Elevated levels of MT mRNA are observed by
northern blotting in stimulated epidermal cells, and increased expression
of MT genes or protein levels is observed in skin tumors, including
papilloma (Karasawa et al, 1991) and basal cell carcinoma (Rossen et al,
1997), in which epidermal cells continue to grow. These observations
lead to the hypothesis that MT is directly or indirectly associated with
the proliferation of epidermal keratinocytes.
Examining epidermal proliferation in mice with targeted disruption
of the MT genes could provide direct evidence confirming the previous
hypothesis. Recently, mutant mice deficient in the MT-1 and MT-2
genes (MT-null mouse) have been produced by homologous recomb-
ination (Michalska and Choo, 1993; Masters et al, 1994).
To clarify the significance of MT production in epidermal hyperpla-
sia, we examined the proliferative response of the skin in MT-null
mice after localized treatments with cholera toxin, TPA (Ohtake et al,
1978; Kuroki, 1981), and ultraviolet B (UVB) irradiation (Verma et al,
1979; Anstey et al, 1996) to stimulate epidermal hyperplasia. In addition,
the concentrations in the skin of essential metals, zinc, and copper,
which participate in several enzymatic reactions, were measured to
assess the activity.
MATERIALS AND METHODS
Reagents and chemicals The catalyzed signal amplification system, a modi-
fied avidin-biotin peroxidase complex kit, and mouse monoclonal antibody
raised against horse self-polymerized MT-1 and MT-2, were purchased from
260 HANADA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Dako (Carpinteria, CA). Both cholera toxin and TPA were purchased from
Wako Pure Chemical Industries (Tokyo, Japan).
Animals MT-null mice (Michalska and Choo, 1993), which were of a mixed
genetic background of 129 Ola and C57BL/6 strains, were provided by Dr. C.
Tohyama (Environmental Health Science Division, National Institute for
Environmental Studies in Japan). To produce these MT-null mice, F1 hybrid
mice were mated with C57BL/6 mice and their offspring were back-crossed
to C57BL/6 for three generations. F generation was 10 (F88.6). For wild-
type control mice, male C57BL/6 J mice were obtained from Japan Clea
(Tokyo, Japan).
UVB radiation source A bank of seven fluorescent sunlamps, FL20SE.30
(Toshiba Medical Supply, Tokyo, Japan) emitting rays between 275 and 305 nm
with a peak at 305 nm, was used as the UVB source. The radiation dose was
measured using a radiometer (model UVR 305/365D (II), Toshiba Medical
Supply). The lamp-to-skin distance was 45 cm.
Immunohistochemical staining Deparaffinized sections were stained using
the catalyzed signal amplification system as described elsewhere (Bobrow et al,
1989). In brief, tissue sections were immersed in a 3.0% hydrogen peroxide
solution for 5 min to mask endogenous peroxidase activity, rinsed with
phosphate-buffered saline, and treated with a 0.25% casein for 5 min. The
sections were overlaid with monoclonal mouse antibody raised against horse
MT (500-fold dilution) at room temperature (20–25°C) for 1 h. The sections
were then treated with biotinylated rabbit anti-mouse IgG for 15 min, washed
with phosphate-buffered saline, and treated with the avidin-biotin complex,
amplification reagent (biotinyl tyramide and hydrogen peroxide), and streptoavi-
din-peroxidase each for 15 min. The sections were stained with 0.05% 3–39-
diaminobenzidine solution in 0.8% hydrogen peroxide, counter stained with
hematoxylin, dehydrated, cleared, and mounted. Control sections were treated
with nonimmune mouse IgG instead of monoclonal mouse antibody for MT.
Animal experiments Five MT-null mice and five C57BL/6 J mice, aged
9–12 wk, were used. Before each procedure, all the mice were anesthetized
using chloral hydrate (2.9 g per kg body weight) by intraperitoneal injection.
After anesthetization, the skin on the animals’ backs was shaved. Localized
hyperplasia of the skin was induced by subcutaneous injection of cholera toxin,
by the topical application of TPA, and by UVB irradiation in each animal.
Appropriate doses of the stimulators were decided on in accordance with
previous reports (Karasawa et al, 1991; Hanada et al, 1991). A stock solution of
cholera toxin was prepared by dissolving it at 1 mg per ml in 0.5 M Tris buffer
(pH 8.0) with lactose (50 mg per ml) as a stabilizer. Immediately before
injection, the stock solution was diluted with cold phosphate-buffered saline
and 0.1 ml of the diluted solution, containing 0.1, 1.0, or 10 ng of cholera
toxin, was injected into the back skin. TPA was dissolved in acetone to a
concentration of 1 mg per ml and 100, 200, or 300 µl was applied to the back
skin. The dose of UVB irradiation was 100 or 200 mJ per cm2, corresponding
to 1- and 2-fold minimal erythema doses. Control skin was obtained from
vehicle-treated or nonirradiated sites in each mouse. The skin was biopsied
48 h after the treatments, fixed in 10% formalin, and embedded in paraffin.
Sectioned specimens were subjected to hematoxylin and eosin staining for
measurement of epidermal thickness or to immunohistochemical staining
for MT.
The thickness of the epidermis was measured using a light microscope fitted
with an eyepiece grid. The epidermal thickness of the treated site divided by
the thickness of the control site (epidermal thickness ratio) for the MT-null
mice was compared with that in C57BL/6 J mice that had received the
same treatments.
Analysis of metals in the skin Proton-induced x-ray emission (PIXE)
analysis, which is a sensitive and analytical method for biologic samples (Stedman
and Spyrou, 1995), was applied to the determination of the metal content of
the skin. Fifty milligram skin samples were obtained from nontreated sites of
the skin of the back and from sites treated with 10 ng of cholera toxin, 300 ng
of TPA, or 200 mJ UVB per cm2. After washing with deionized water, each
sample was dissolved in 60% nitric acid and an equal volume of a standard
solution of indium (Wako Pure Chemical Industries). After heating the sample
solution in a 200 W microwave oven twice for 2 min, 5 µl of the sample was
dried on a polypropylene film. The zinc and copper concentrations were
determined using a PIXE analyzer, Ortec (Shimazu Seisaku, Tokyo, Japan),
running the element analytical program SAPI (NEC, Tokyo, Japan). The PIXE
analysis was performed at the Institute of Nishina Memorial Cyclotron Center
in Takizawa, Iwate, Japan.
RESULTS
Expression of MT in hyperplastic epidermis Immuno-
histochemical staining for MT in the skin of both animals is shown in
Figure 1. MT-null mice lack immunohistochemical staining for MT.
The dorsal skin of a normal mouse showed weak immunoreactivity for MT in
the basal layer of nontreated skin (a). Strong immunoreactivity was found
through the hyper plastic epidermis induced by injection of 10 ng cholera toxin
in the control mouse (b). By contrast, immunoreactivity was not detected in
the skin of the MT-null mouse before (c) and after (d) cholera toxin treatment.
Scale bar, 20 µm.
Figure 2. MT-null mice show less development in histologic hyperplasia
in the epidermis. The dorsal skin of the normal mouse (a–d) and the MT-
null mouse (e–h) revealed epidermal hyperplasia 48 h after treatments with
stimulators. Control skin in the normal (a) and the MT-null mouse (e) showed
almost the same epidermal thickness. Epidermal proliferation was greater in the
control mouse than in the MT-null mouse (hematoxylin and eosin stain). (b, f)
Cholera toxin-treated skin; (c, g) TPA-treated skin; (d, h) UVB-treated skin. →
indicate the thickness of each epidermis. Scale bar, 45 µm.
Fig 1. Normal mice showed weak immunoreactivity for MT in the
basal cells of the epidermis of nontreated skin (Fig 1a). Treatment of
normal mice with the stimulators resulted in strong MT staining
throughout the epidermis, except the horny layer, with a diffuse
intracellular pattern of staining in the cytoplasm (Fig 1b). By contrast,
in the MT-null mice, nontreated sites (Fig 1c) and sites treated locally
with cholera toxin (Fig 1d), TPA, and UVB irradiation (data not
shown) showed a complete absence of MT staining in the epidermis
and dermis.
Epidermal hyperplasia Histologic findings of epidermal hyperplasia
caused by stimulators are shown in Fig 2. Although nontreated skin
in both animals (Fig 1a, b) revealed almost the same epidermal
thickness, 48 h after local treatments with cholera toxin, TPA and UVB
irradiation caused epidermal hyperplasia in both animals. Epidermal
proliferation of normal mouse skin (Fig 2b–d) was greater than that
of MT-null mouse (Fig 2f–h).
The mean values of the thickness ratios of treated and nontreated
epidermis are shown in Fig 3. In MT-null mice, the epidermis of the
treated sites was about 2-fold thicker than the vehicle-treated or
nontreated sites 48 h after the treatments. Whereas the normal mice
showed various levels of epidermal hyperplasia, which was about 4-
fold thicker than the control sites. As a result, the epidermal thickness
ratio for the MT-null mice was significantly lower than that for normal
mice for each treatment: cholera toxin at doses of 0.1 ng (p , 0.05),
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Figure 3. MT-null mice show a low level of epidermal hyperplasia after
stimulation by proliferation agents. The epidermal thickness ratios of treated
to nontreated sites in MT-null mice (u) were less than those in normal mice
(j). In the control mice, cholera toxin treatments dose-dependently increase
the ratios. There were significant differences between the ratios for 0.1 and
1.0 ng cholera toxin (p , 0.05), and 1.0 ng and 10 ng cholera toxin (p , 0.053).
The other treatments caused significantly different ratios for control mice treated
with TPA doses of 100 ng and 300 ng (p , 0.05), and for UVB irradiation
doses of 100 and 200 mJ per cm2 (p , 0.001). No significant differences were
recognized among the ratios for MT-null mice exposed to each stimulator. The
ratios of epidermal thickness are expressed as the mean 6 SD (n 5 5). Statistical
significance was assessed by Student’s t test (*p , 0.05; **p , 0.01,
***p , 0.001).
Table I. Zinc and copper levels in the skin of normal and
MT-null micea
Normal mice (5) MT-null mice (5)
Zinc Copper Zinc Copper
No treatment 14.9 6 0.1 1.4 6 0.2 9.2 6 0.1 2.0 6 0.9
Cholera toxin 11.6 6 0.1 0.8 6 0.2 7.0 6 0.1 1.4 6 0.1
TPA 12.2 6 0.2 1.1 6 0.5 7.2 6 0.1 1.8 6 0.4
UVB 11.5 6 0.1 1.2 6 0.1 7.0 6 0.1 1.8 6 0.1
aZinc and copper concentrations of mouse skin obtained from normal and MT-null
mice were determined using PIXE method. Back skin of the animals was injected with
10 ng cholera toxin, applied with 300 ng TPA, or irradiated by 200 mJ UVB per cm2 to
induce epidermal hyperplasia. Data are presented as the means 6 SD per wet weight of
skin samples (µg per g). The numbers in parentheses indicate the number of mice in
each group.
1.0 ng (p , 0.01), and 10 ng (p , 0.01); TPA at doses of 100 ng
(p , 0.01), 200 ng (p , 0.001), and 300 ng (p , 0.001); and UVB
irradiation at doses of 100 mJ per cm2 (p , 0.001) and 200 mJ per
cm2 (p , 0.001). Although MT-null mice showed steady or slightly
increasing hyperplasia, the thickness ratios of the normal mice increased
dose dependently for each treatment. There were significant differences
between the thickness ratios of the sites injected with 0.1 and 1.0 ng
(p , 0.05) and 1.0 and 10 ng cholera toxin (p , 0.05), between the
sites treated with 100 and 300 ng TPA (p , 0.05), and between the
sites irradiated with 100 and 200 mJ UVB per cm2 (p , 0.001). The
epidermal thicknesses of the vehicle-treated and nonirradiated skin
were not significantly different.
Zinc and copper contents The mean concentrations of the ele-
ments are given in Table I. There was a significant difference in the
concentration of zinc between the back skin of normal animals and
the control sites of the MT-null animals, the latter was lower than that
of normal mice (p , 0.05). The treated sites of normal and MI-null
mice had lower concentrations of zinc than the control sites of each
group of animals (p , 0.05, p , 0.01). By contrast, the copper
concentration in the MT-null mice tended to be high compared with
that in the normal mice before stimulation, and there was a significant
difference between the control site of the MT-null mice and the
injected site with cholera toxin (p , 0.05).
DISCUSSION
As well as having a role in metal homeostasis, MT has scavenging
activity for superoxide and hydroxyl radicals through its cysteine-rich
property (Thornalley and Vasak, 1985; Hanada et al, 1993). Animals
given inducers of MT synthesis gain improved tolerance against
oxygen-mediated damage caused by x-rays (Shitraishi et al, 1983) and
chemotherapy (Naganuma et al, 1987). We previously demonstrated
that increasing MT synthesis suppressed UVB-mediated sunburn cell
formation in the mouse skin (Hanada et al, 1991), suggesting a
protective effect of MT protein. In addition, Karasawa et al (1991)
proposed that MT may be involved in proliferation of epidermal cells.
To understand the role of MT in epidermal hyperplasia, MT-null
mice were examined in this study. We compared the epidermal
thicknesses of MT-null mice and normal mice after exposure to
agents that stimulate cell proliferation: cholera toxin, TPA, and UVB
irradiation. In normal mice, positive immunohistochemical staining for
MT was observed in the basal cells of the skin, and the intensity was
increased by treatment with these stimulators. In MT-null mice, MT
immunoreactivity was hardly observed in the skin with or without
stimulation of the cell proliferation. These findings strongly indicate
that cellular MT plays a significant role in epidermal hyperplasia
induced by cholera toxin, TPA, and UVB light. Ohtake et al (1978)
discussed the mode of action of MT, and suggested that MT might
promote the synthesis of nucleic acids and proteins by supplying zinc
to the enzymes involved in their synthesis. Actually, zinc is a cofactor
of DNA and RNA polymerases, and is an important constituent of
the zinc finger of nuclear proteins. Quaife et al (1994) demonstrated a
new member of the MT gene family, MT-IV, which is different from
MT-1 and MT-2 genes in both mouse and human. Murine MT-IV
mRNA appears to be expressed exclusively in stratified squamous
epithelia including the tail, footpads, and neonatal skin. They suggest
that MT-IV plays a special role in regulating zinc metabolism during
the differentiation of stratified epithelia. When the mouse with null
mutation in their MT-IV gene with other MTs’ is produced, more
dominant effects of low epidermal proliferation might be seen. In this
study, PIXE analysis demonstrated a low level of zinc, and a high level
of copper in the skin of MT-null mice compared with those in the
normal mice. As zinc and copper have a reciprocal activity in metal
metabolism, and MT is known to bind copper as well as zinc, low
levels of zinc content may yield an increase of copper content in the
skin. Moreover, the zinc level was significantly reduced by treatment
with cholera toxin, TPA, and UVB light. It is possible to conclude
that MT may be involved in the epidermal hyperplasia by maintaining
essential zinc concentration.
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